About Urology Services at Mount Sinai
Ranked among the nation’s best in the region in the 2013-2014 "Best Hospitals" issue of U.S. News & World Report, the Milton and Carroll Petrie Department of Urology at The Mount Sinai Hospital provides the most up-to-date services available for the diagnosis, treatment, prevention, and management of a wide variety of urologic conditions, including prostate, bladder, and kidney cancers. Our physicians are fellowship-educated clinicians and researchers who are leaders in advancing emerging diagnostic techniques and treatments in the field of urology. We are trained in open, laparoscopic, and robotic surgery. This combination of expertise makes us uniquely qualified to advise our patients on the best approach.
A hallmark of Mount Sinai Urology Associates’ tradition is providing comprehensive, patient- centered care. We spend time discussing the potential benefits and side effects associated with each treatment with our patients. And we encourage our patients to become as knowledgeable as possible about their condition so the conversation can be truly two-way. Additionally, our approach is uniquely multidisciplinary. We partner with our distinguished colleagues in other departments at Mount Sinai, including Radiology, Medicine, and Oncology (Tisch Cancer Institute) to ensure we are providing comprehensive, personalized and coordinated treatment.
Consistently voted among the country’s top doctors, our team has been recognized for our depth of knowledge, breadth of experience and compassion for patients.
The diseases and conditions we treat include:
The Department of Urology’s Barbara and Maurice Deane Prostate Health and Research Center offers a range of treatment options for the management of cancer that has not spread beyond the prostate gland (localized prostate cancer). Our Robotics Prostatectomy and Minimally Invasive Surgery program is one of the world’s busiest. Our research has assisted in the development of innovative therapies, including Provenge® (sipuleucel-T), the vaccine for prostate cancer approved by the U.S. Food and Drug Administration in 2010.
As recognized leaders in the assessment and treatment of all forms of bladder cancer, Mount Sinai urologic oncologists are successfully using tumor markers and new diagnostic techniques. Our surgeons employ robotic and laparoscopic surgery to perform cystectomies (removal of bladder) resulting in minimal impact on quality of life.
Mount Sinai specialists helped pioneer robotic partial nephrectomy for the treatment of small kidney cancers. Other minimal invasive options such as cryoablation (freezing) or radiofrequency ablation (heating) are offered as a means to treat small cancers while preserving maximum kidney function.
Benign Prostatic Hyperplasia (BPH)
The Barbara and Maurice Deane Prostate Health and Research Center offers the latest, minimally invasive technologies and treatments for benign prostatic hyperplasia (BPH), including holium laser enucleation of the prostate (HoLEP), Greenlight ™ Laser PVP treatment, and bipolar cautery vaporization (Button TURP), in addition to TURP. Many of these procedures can be performed on an outpatient basis.
Reconstructive Urology, Female Urology and Voiding Dysfunction
The Department of Urology provides comprehensive resources for the evaluation and treatment of urinary incontinence, neuro-urological problems caused by diseases such as multiple sclerosis and diabetes mellitus and pelvic pain syndrome for both men and women. Our specialists are among the few in the country with advanced training in urethral reconstruction. A state-of-the-art Continence Center provides the convenience of on-site diagnosis and treatment.
Erectile Dysfunction and Infertility
The Mount Sinai Sexual Health Program uses the most advanced techniques available to evaluate the causes of erectile dysfunction. Treatment options are extensive and have high success rates. Importantly, patients and their partners receive the guidance they need to make the appropriate personal decision regarding treatment.
Mount Sinai’s specialists utilize minimally invasive procedures to treat urologic kidney stones, including laser and ultrasonic lithotripsy techniques. Medical and surgical care is highly customized based on type of stone and its size.
Mount Sinai’s state-of-the-art use of medications, in vitro fertilization techniques and microsurgical repairs have resulted in high success rates.
Mount Sinai excels in treating urologic problems in newborns, infants, children, and adolescents. The Division of Pediatric Urology offers the latest minimally invasive treatments, including robotic-assisted surgery for major reconstructive procedures.